Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Hexima Limited
  6. News
  7. Summary
    HXL   AU0000111932

HEXIMA LIMITED

(HXL)
  Report
Delayed Quote. Delayed Australian Stock Exchange - 01/24 11:07:12 pm
0.375 AUD   -2.60%
01/03Hexima Appoints Commercial Chief
MT
01/03Phillip Rose Appoints Phillip Rose as Chief Commercial Officer
CI
2021HEXIMA : Notification regarding unquoted securities - HXL
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Hexima : Application for quotation of securities - HXL

11/25/2021 | 07:20pm EST

Application for quotation of +securities

Announcement Summary

For personal use only

Entity name

HEXIMA LIMITED.

Announcement Type

New announcement

Date of this announcement

Friday November 26, 2021

The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Total number of +securities to be quoted

ASX +security

Number of +securities to

code

Security description

be quoted

Issue date

HXL

ORDINARY FULLY PAID

3,125,317

26/11/2021

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 6

Application for quotation of +securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

HEXIMA LIMITED.

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2

Registered number type

Registration number

ABN

64079319314

1.3

ASX issuer code

HXL

  1. The announcement is New announcement
  2. Date of this announcement

26/11/2021

Application for quotation of +securities

2 / 6

Application for quotation of +securities

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

For personal use only

Previous Appendix 3B details:

Announcement Date and

Announcement Title

Selected Appendix 3B to submit quotation

Time

request

01-Nov-2021 09:53

New - Proposed issue of securities -

An offer of +securities under a +securities

HXL

purchase plan

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?

Yes

2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B

Tranche 2 of a placement (being the issue of 11,650,000 shares), is conditional on Hexima's shareholders approving the issue for the purpose of ASX Listing Rule 7.1 at Hexima's AGM on 2 December 2021, as outlined in the ASX announcement and Investor Presentation released to ASX on 1 November 2021.

Application for quotation of +securities

3 / 6

Application for quotation of +securities

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

Corporate Action Component Detail

only

ASX +security code and description

HXL : ORDINARY FULLY PAID

Issue date

use

26/11/2021

Distribution Schedule

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column -

including the number of recipients and the total percentage of the new +securities held by the recipients in each

personalFor

category.

Total percentage of +securities held

Number of +securities held

Number of holders

For example, to enter a value of 50%

please input as 50.00

1 - 1,000

82

0.03 %

1,001 - 5,000

253

0.51 %

5,001 - 10,000

176

0.89 %

10,001 - 100,000

477

10.92 %

100,001 and over

152

87.66 %

Application for quotation of +securities

4 / 6

Application for quotation of +securities

Issue details

Number of +securities to be quoted

3,125,317

For personal use only

Issue currency

Issue price or consideration per +security

AUD - Australian Dollar

AUD 0.32000000

Any other information the entity wishes to provide about the +securities to be quoted

No

Application for quotation of +securities

5 / 6

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Hexima Limited published this content on 26 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 November 2021 00:19:10 UTC.


© Publicnow 2021
All news about HEXIMA LIMITED
01/03Hexima Appoints Commercial Chief
MT
01/03Phillip Rose Appoints Phillip Rose as Chief Commercial Officer
CI
2021HEXIMA : Notification regarding unquoted securities - HXL
PU
2021HEXIMA : Notification regarding unquoted securities - HXL
PU
2021Hexima Names New Chief Development Officer
MT
2021HEXIMA : CEO's Presentation
PU
2021Hexima Limited Announces Cessation of Marilyn Anderson as Executive Director
CI
2021Hexima Limited Announces Appointment of Shari Lipner as Member of its Scientific Adviso..
CI
2021Hexima Limited Announces Appointment of Nancy Sacco as Chief Development Officer
CI
2021Hexima Completes Oversubscribed Share Purchase Plan
MT
More news
Financials
Sales 2022 - - -
Net income 2022 -9,30 M -6,65 M -6,65 M
Net cash 2022 41,5 M 29,7 M 29,7 M
P/E ratio 2022 -6,43x
Yield 2022 -
Capitalization 62,0 M 44,3 M 44,3 M
EV / Sales 2022 -
EV / Sales 2023 -
Nbr of Employees -
Free-Float 69,6%
Chart HEXIMA LIMITED
Duration : Period :
Hexima Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,38 AUD
Average target price 0,75 AUD
Spread / Average Target 100%
EPS Revisions
Managers and Directors
Michael Douglas Arthur Aldridge CEO, Non-Independent Non-Executive Director & MD
Jonathan West Non-Executive Chairman
Marilyn Ann Anderson Chief Scientific Officer
Yolanda Gaspar Head-Clinical Operations
Nicole Louise van der Weerden Director
Sector and Competitors
1st jan.Capi. (M$)
HEXIMA LIMITED-9.64%45
MODERNA, INC.-38.07%63 777
LONZA GROUP AG-19.59%49 711
IQVIA HOLDINGS INC.-13.62%46 556
SEAGEN INC.-16.20%23 689
ICON PUBLIC LIMITED COMPANY-17.32%20 842